Pharma's Criminal Business Model -- and How the U.S. Government Benefits From It
• By Childrens Health Defense TeamIn early September, the U.S. Department of Justice (DOJ) announced that pharma giant Bayer would have to fork over millions to the DOJ to resolve allegations of fraud under the False Claims Act (FCA).
